|
Orthologous residues
|
|
ITGB3 (human): Y773‑p, ITGB3 iso5 (human): ‑, ITGB3 (mouse): Y772‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, peptide sequencing
|
|
Relevant cell lines - cell types - tissues:
K562 (erythroid)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
RGD
|
|
|
|
increase
|
|
|